Protalix Biotherapeutics' Reverse Merger Round

Protalix Biotherapeutics raised a round of funding on August 22, 2006. Investors include Orthodontix.

Protalix Biotherapeutics is a biopharmaceutical company that specializes in the manufacture of recombinant therapeutic proteins through its ProCellEx plant cell-based protein expression system. Using …

Articles about Protalix Biotherapeutics' Reverse Merger Round: